Inventor · disambiguated record
Ronald Palin
Also filed as: PALIN RONALD
8 granted patents·4 pending applications·96 citations·filing 2000–2011
85Inventor score
Top patents by PatentIndex Score
12 records- 0190US7482469B22-(benzimidazol-1-yl)-acetamide bisaryl derivativesORGANON NV·Filed 2006·Granted Jan 27, 2009·35 cites·18 claims
- 0288US6670340B16-Mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular blockAKZO NOBEL·Filed 2000·Granted Dec 30, 2003·40 cites·9 claims
- 0384US8946224B2Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositionsCRAIGHEAD MARK·Filed 2011·Granted Feb 3, 2015·6 cites·10 claims
- 0474USRE44733E6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular blockZHANG MINGIANG·Filed 2000·Granted Jan 28, 2014·9 cites·21 claims
- 0571US6949527B26-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular blockAKZO NOBEL NV·Filed 2003·Granted Sep 27, 2005·4 cites·5 claims
- 0667US8211927B25-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulatorsROUGHTON ANDREW LAIRD·Filed 2008·Granted Jul 3, 2012·2 cites·13 claims
- 0752US2010099722A12-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivativesPALIN RONALD·Filed 2009·Application pending·0 cites
- 0850US8188123B2(Pyrrolidin-2-yl)phenyl derivativesGROVE SIMON JAMES ANTHONY·Filed 2009·Granted May 29, 2012·0 cites·23 claims
- 0947US2007105920A12-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivativesAKZO NOBEL NV·Filed 2006·Application pending·0 cites
- 1034US2012071481A1Isoxazole-5-carboxamide derivativesPALIN RONALD·Filed 2010·Application pending·0 cites
- 1131US2012095002A1Isoxazole-5-carboxamide derivativesRATCLIFFE PAUL DAVID·Filed 2010·Application pending·0 cites
- 1229US8952001B2Amino-heteroaryl derivatives as HCN blockersGROVE SIMON JAMES ANTHONY·Filed 2010·Granted Feb 10, 2015·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Ronald Palin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →